Literature DB >> 27449033

Overexpression of p42.3 promotes cell proliferation, migration, and invasion in human gastric cancer cells.

Wen-Jia Cao1,2, Wen-Qi Du1, Lin-Lin Mao1, Jun-Nian Zheng3,4,5, Dong-Sheng Pei6,7,8.   

Abstract

As a newly discovered tumor-specific gene, p42.3 is overexpressed in most of human gastric cancers (GC). However, the role of p42.3 in GC progression remains unclear. To assess the role of p42.3 in gastric cancers, immunohistochemistry and western blot were performed to detect the p42.3 expression in human GC tissues and cells. We also investigated the role of p42.3 in GC cell proliferation, migration, and invasion. Our results showed that the p42.3 expression was increased dramatically in human GC tissue and cells. In addition, we found that overexpression of p42.3 promotes GC cell proliferation, migration, and invasion abilities. Furthermore, p42.3 expression suppressed the E-cadherin protein level and promoted the β-catenin and p-ERK protein level. Taken together, overexpressed p42.3 is correlated with gastric cancer cell proliferation, migration, and invasion, suggesting its use as a biological marker in gastric cancer.

Entities:  

Keywords:  E-cadherin; ERK; Invasion; Proliferation; p42.3; β-catenin

Mesh:

Substances:

Year:  2016        PMID: 27449033     DOI: 10.1007/s13277-016-5242-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Etiology and prevention of gastric cancer: a population study in a high risk area of China.

Authors:  Wei Cheng You; Ji You Li; Lian Zhang; Mao Lin Jin; Yun Sheng Chang; Jun Ling Ma; Kai Feng Pan
Journal:  Chin J Dig Dis       Date:  2005

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Authors:  Robert L Strausberg; Elise A Feingold; Lynette H Grouse; Jeffery G Derge; Richard D Klausner; Francis S Collins; Lukas Wagner; Carolyn M Shenmen; Gregory D Schuler; Stephen F Altschul; Barry Zeeberg; Kenneth H Buetow; Carl F Schaefer; Narayan K Bhat; Ralph F Hopkins; Heather Jordan; Troy Moore; Steve I Max; Jun Wang; Florence Hsieh; Luda Diatchenko; Kate Marusina; Andrew A Farmer; Gerald M Rubin; Ling Hong; Mark Stapleton; M Bento Soares; Maria F Bonaldo; Tom L Casavant; Todd E Scheetz; Michael J Brownstein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Christa Prange; Sam S Raha; Naomi A Loquellano; Garrick J Peters; Rick D Abramson; Sara J Mullahy; Stephanie A Bosak; Paul J McEwan; Kevin J McKernan; Joel A Malek; Preethi H Gunaratne; Stephen Richards; Kim C Worley; Sarah Hale; Angela M Garcia; Laura J Gay; Stephen W Hulyk; Debbie K Villalon; Donna M Muzny; Erica J Sodergren; Xiuhua Lu; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madan; Alice C Young; Yuriy Shevchenko; Gerard G Bouffard; Robert W Blakesley; Jeffrey W Touchman; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Martin I Krzywinski; Ursula Skalska; Duane E Smailus; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Marco A Marra
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

4.  Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.

Authors:  M Toyota; N Ahuja; H Suzuki; F Itoh; M Ohe-Toyota; K Imai; S B Baylin; J P Issa
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

5.  Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer.

Authors:  X Xu; W Li; X Fan; Y Liang; M Zhao; J Zhang; Y Liang; W Tong; J Wang; W Yang; Y Lu
Journal:  Oncogene       Date:  2007-05-21       Impact factor: 9.867

6.  p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.

Authors:  Xiao-Sun Yuan; Yi Zhang; Xiao-Ya Guan; Bin Dong; Min Zhao; Lin-Lin Mao; You-Yong Lu; Xiu-Yun Tian; Chun-Yi Hao
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-11       Impact factor: 4.553

Review 7.  The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis.

Authors:  Konstantinos A Paschos; David Canovas; Nigel C Bird
Journal:  Cell Signal       Date:  2009-01-07       Impact factor: 4.315

8.  Cell cycle-dependent expression of p42.3 promotes mitotic progression in malignant transformed cells.

Authors:  Linlin Mao; Wei Sun; Wenmei Li; Jiantao Cui; Jingyu Zhang; Rui Xing; Youyong Lu
Journal:  Mol Carcinog       Date:  2012-11-28       Impact factor: 4.784

9.  Differential expression of p42.3 in low- and high-grade gliomas.

Authors:  Weiqing Wan; Xiaoqing Xu; Guijun Jia; Wenmei Li; Junmei Wang; Tong Ren; Zhen Wu; Junting Zhang; Liwei Zhang; Youyong Lu
Journal:  World J Surg Oncol       Date:  2014-06-14       Impact factor: 2.754

10.  p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis.

Authors:  Jianhua Zhang; Chunlei Lu; Zhigang Shang; Rui Xing; Li Shi; Youyong Lv
Journal:  Theor Biol Med Model       Date:  2012-12-11       Impact factor: 2.432

View more
  3 in total

Review 1.  The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes.

Authors:  Amy L Baker; Liqin Du
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

2.  Promotion of SH-SY5Y Cell Growth by Gold Nanoparticles Modified with 6-Mercaptopurine and a Neuron-Penetrating Peptide.

Authors:  Yaruo Xiao; Enqi Zhang; Ailing Fu
Journal:  Nanoscale Res Lett       Date:  2017-12-29       Impact factor: 4.703

3.  Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cells.

Authors:  Yage Luo; Lili Wang; Wenwen Ran; Guangqi Li; Yujing Xiao; Xiaonan Wang; Han Zhao; Xiaoming Xing
Journal:  Cancer Cell Int       Date:  2020-02-06       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.